title: The efficacy of lopinavir in individuals experiencing protease inhibitor failure.
authors.forename: Yvonne C
authors.initials: YC
authors.lastname: Gilleece
authors.forename: Nad A
authors.initials: NA
authors.lastname: Qazi
authors.forename: John F
authors.initials: JF
authors.lastname: Morlese
authors.forename: Sundhiya
authors.initials: S
authors.lastname: Mandalia
authors.forename: Brian G
authors.initials: BG
authors.lastname: Gazzard
authors.forename: Anton L
authors.initials: AL
authors.lastname: Pozniak
authors.forename: Mark R
authors.initials: MR
authors.lastname: Nelson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000628:therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011480:Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir